Annual report
7915.TEDINET S100VFAX
Period2024-01-01 → 2024-12-31
Filed2025-03-21
StandardIFRS
ConsolidatedYes
Data checks19 of 19 passed
Key figures · 151
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥195.6bn | 2024-01-01 → 2024-12-31 | Cons. | Revenue IFRS |
| Revenue | ¥167.7bn | 2023-01-01 → 2023-12-31 | Cons. | Revenue IFRS |
| Revenue | ¥194.0bn | 2022-01-01 → 2022-12-31d | Cons. | Net sales IFRS (5-year summary) |
| Revenue | ¥189.3bn | 2021-01-01 → 2021-12-31d | Cons. | Net sales IFRS (5-year summary) |
| Revenue | ¥180.0bn | 2020-01-01 → 2020-12-31d | Cons. | Net sales IFRS (5-year summary) |
| Operating income | ¥5.5bn | 2024-01-01 → 2024-12-31 | Cons. | Operating profit loss IFRS |
| Operating income | −¥3.8bn | 2023-01-01 → 2023-12-31 | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥6.2bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | −¥2.8bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥12.4bn | 2022-01-01 → 2022-12-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥19.5bn | 2021-01-01 → 2021-12-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥7.0bn | 2020-01-01 → 2020-12-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Net income (owners) | ¥3.9bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | −¥3.0bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥10.1bn | 2022-01-01 → 2022-12-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥15.9bn | 2021-01-01 → 2021-12-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥7.1bn | 2020-01-01 → 2020-12-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income | ¥4.0bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss IFRS |
| Net income | −¥3.0bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss IFRS |
| Total assets | ¥250.8bn | at 2024-12-31 | Cons. | Assets IFRS |
| Total assets | ¥217.9bn | at 2023-12-31 | Cons. | Assets IFRS |
| Total assets | ¥230.2bn | at 2022-12-31d | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥209.3bn | at 2021-12-31d | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥199.6bn | at 2020-12-31d | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥135.3bn | at 2024-12-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥107.0bn | at 2023-12-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥115.5bn | at 2024-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥110.9bn | at 2023-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥111.5bn | at 2022-12-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥114.2bn | at 2024-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥110.9bn | at 2023-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥111.6bn | at 2022-12-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥98.3bn | at 2021-12-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥81.9bn | at 2020-12-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥51.0bn | at 2024-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥37.9bn | at 2023-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥54.3bn | at 2022-12-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Cash & equivalents | ¥42.3bn | at 2021-12-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Cash & equivalents | ¥25.1bn | at 2020-12-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Operating cash flow | ¥12.3bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥1.5bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥12.0bn | 2022-01-01 → 2022-12-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥18.8bn | 2021-01-01 → 2021-12-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥14.6bn | 2020-01-01 → 2020-12-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Investing cash flow | −¥11.4bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥8.0bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥4.4bn | 2022-01-01 → 2022-12-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥6.9bn | 2021-01-01 → 2021-12-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥1.4bn | 2020-01-01 → 2020-12-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Financing cash flow | ¥9.1bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥12.6bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | ¥1.1bn | 2022-01-01 → 2022-12-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | ¥2.6bn | 2021-01-01 → 2021-12-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥6.0bn | 2020-01-01 → 2020-12-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| EPS (basic) | ¥80.15 | 2024-01-01 → 2024-12-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥-61.13 | 2023-01-01 → 2023-12-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥203.65 | 2022-01-01 → 2022-12-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥318.35 | 2021-01-01 → 2021-12-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥141.34 | 2020-01-01 → 2020-12-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥317.16 | 2021-01-01 → 2021-12-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥137.78 | 2020-01-01 → 2020-12-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| Net assets per share | ¥2,391.31 | at 2024-12-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥2,281.64 | at 2023-12-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥2,257.47 | at 2022-12-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥1,972.89 | at 2021-12-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥1,638.46 | at 2020-12-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Equity ratio | 45.5% | at 2024-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 50.9% | at 2023-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 48.5% | at 2022-12-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 47.0% | at 2021-12-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 41.1% | at 2020-12-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| ROE | 3.4% | 2024-01-01 → 2024-12-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | -2.7% | 2023-01-01 → 2023-12-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 9.7% | 2022-01-01 → 2022-12-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 17.6% | 2021-01-01 → 2021-12-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 9.0% | 2020-01-01 → 2020-12-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| Employees | 5,397 | at 2024-12-31 | Cons. | Number of employees |
| Employees | 5,221 | at 2023-12-31 | Cons. | Number of employees |
| Employees | 5,325 | at 2022-12-31d | Cons. | Number of employees |
| Employees | 5,409 | at 2021-12-31d | Cons. | Number of employees |
| Employees | 5,390 | at 2020-12-31d | Cons. | Number of employees |
| Revenue | ¥84.9bn | 2024-01-01 → 2024-12-31 | Standalone | Net sales |
| Revenue | ¥68.9bn | 2023-01-01 → 2023-12-31 | Standalone | Net sales |
| Revenue | ¥93.5bn | 2022-01-01 → 2022-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥113.0bn | 2021-01-01 → 2021-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥115.7bn | 2020-01-01 → 2020-12-31d | Standalone | Net sales (5-year summary) |
| Operating income | −¥2.8bn | 2024-01-01 → 2024-12-31 | Standalone | Operating income |
| Operating income | −¥3.4bn | 2023-01-01 → 2023-12-31 | Standalone | Operating income |
| Ordinary income | ¥968m | 2024-01-01 → 2024-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥1.8bn | 2023-01-01 → 2023-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥9.9bn | 2022-01-01 → 2022-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥6.9bn | 2021-01-01 → 2021-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.6bn | 2020-01-01 → 2020-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥9.3bn | 2024-01-01 → 2024-12-31 | Standalone | Income before income taxes |
| Profit before tax | −¥4.9bn | 2023-01-01 → 2023-12-31 | Standalone | Income before income taxes |
| Net income | ¥6.5bn | 2024-01-01 → 2024-12-31 | Standalone | Profit loss |
| Net income | −¥4.5bn | 2023-01-01 → 2023-12-31 | Standalone | Profit loss |
| Net income | ¥10.8bn | 2022-01-01 → 2022-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥6.2bn | 2021-01-01 → 2021-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥5.5bn | 2020-01-01 → 2020-12-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥161.4bn | at 2024-12-31 | Standalone | Assets |
| Total assets | ¥142.9bn | at 2023-12-31 | Standalone | Assets |
| Total assets | ¥159.2bn | at 2022-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥150.3bn | at 2021-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥154.0bn | at 2020-12-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥80.3bn | at 2024-12-31 | Standalone | Liabilities |
| Total liabilities | ¥58.8bn | at 2023-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥81.1bn | at 2024-12-31 | Standalone | Net assets |
| Net assets / equity | ¥84.1bn | at 2023-12-31 | Standalone | Net assets |
| Net assets / equity | ¥90.7bn | at 2022-12-31d | Standalone | Net assets |
| Net assets / equity | ¥85.3bn | at 2021-12-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥81.5bn | at 2020-12-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥30.4bn | at 2024-12-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥15.2bn | at 2023-12-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥135.04 | 2024-01-01 → 2024-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-91.35 | 2023-01-01 → 2023-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥217.18 | 2022-01-01 → 2022-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥124.85 | 2021-01-01 → 2021-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥110.97 | 2020-01-01 → 2020-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥124.38 | 2021-01-01 → 2021-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥108.17 | 2020-01-01 → 2020-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥50 | 2024-01-01 → 2024-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥50 | 2023-01-01 → 2023-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥50 | 2022-01-01 → 2022-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥40 | 2021-01-01 → 2021-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥30 | 2020-01-01 → 2020-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥1,699.49 | at 2024-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,729.67 | at 2023-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,836.15 | at 2022-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,711.67 | at 2021-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,629.17 | at 2020-12-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 50.3% | at 2024-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 58.8% | at 2023-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 57.0% | at 2022-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 56.7% | at 2021-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 52.9% | at 2020-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 7.9% | 2024-01-01 → 2024-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | -5.1% | 2023-01-01 → 2023-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 12.3% | 2022-01-01 → 2022-12-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.5% | 2021-01-01 → 2021-12-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.9% | 2020-01-01 → 2020-12-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 50,855,000 | at 2024-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 50,855,000 | at 2023-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 50,855,000 | at 2022-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 50,855,000 | at 2021-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 50,855,000 | at 2020-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 758 | at 2024-12-31 | Standalone | Number of employees |
| Employees | 720 | at 2023-12-31 | Standalone | Number of employees |
| Employees | 710 | at 2022-12-31d | Standalone | Number of employees |
| Employees | 731 | at 2021-12-31d | Standalone | Number of employees |
| Employees | 720 | at 2020-12-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 48
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-01-01 → 2024-12-31 | ¥9.3bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2024-12-31 | ¥11.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-01-01 → 2024-12-31 | −¥731m |
| Reconciling Itemsreconciling | revenue | 2024-01-01 → 2024-12-31 | −¥1.1bn |
| Reconciling Itemsreconciling | segment assets | at 2024-12-31 | ¥68.6bn |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-12-31 | −¥2.9bn |
| Devicesreportable segment | employees | at 2024-12-31 | 859 pure |
| Devicesreportable segment | revenue | 2024-01-01 → 2024-12-31 | ¥67.6bn |
| Devicesreportable segment | segment assets | at 2024-12-31 | ¥38.8bn |
| Devicesreportable segment | segment profit | 2024-01-01 → 2024-12-31 | ¥1.8bn |
| Industrial Materialsreportable segment | employees | at 2024-12-31 | 2459 pure |
| Industrial Materialsreportable segment | revenue | 2024-01-01 → 2024-12-31 | ¥74.2bn |
| Industrial Materialsreportable segment | segment assets | at 2024-12-31 | ¥64.6bn |
| Industrial Materialsreportable segment | segment profit | 2024-01-01 → 2024-12-31 | ¥4.9bn |
| Medical Technologiesreportable segment | employees | at 2024-12-31 | 1473 pure |
| Medical Technologiesreportable segment | revenue | 2024-01-01 → 2024-12-31 | ¥45.6bn |
| Medical Technologiesreportable segment | segment assets | at 2024-12-31 | ¥67.9bn |
| Medical Technologiesreportable segment | segment profit | 2024-01-01 → 2024-12-31 | ¥2.4bn |
| Other And Corporate R And D Administrativereportable segment | employees | at 2024-12-31 | 606 pure |
| —segment total | revenue | 2024-01-01 → 2024-12-31 | ¥187.3bn |
| —segment total | segment assets | at 2024-12-31 | ¥171.3bn |
| —segment total | segment profit | 2024-01-01 → 2024-12-31 | ¥9.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-01-01 → 2024-12-31 | ¥196.7bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2024-12-31 | ¥182.2bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-01-01 → 2024-12-31 | ¥8.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-01-01 → 2023-12-31 | ¥9.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2023-12-31 | ¥10.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-01-01 → 2023-12-31 | −¥860m |
| Reconciling Itemsreconciling | revenue | 2023-01-01 → 2023-12-31 | −¥1.2bn |
| Reconciling Itemsreconciling | segment assets | at 2023-12-31 | ¥67.8bn |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-12-31 | −¥3.0bn |
| Devicesreportable segment | revenue | 2023-01-01 → 2023-12-31 | ¥54.9bn |
| Devicesreportable segment | segment assets | at 2023-12-31 | ¥34.4bn |
| Devicesreportable segment | segment profit | 2023-01-01 → 2023-12-31 | −¥1.6bn |
| Industrial Materialsreportable segment | revenue | 2023-01-01 → 2023-12-31 | ¥69.0bn |
| Industrial Materialsreportable segment | segment assets | at 2023-12-31 | ¥54.7bn |
| Industrial Materialsreportable segment | segment profit | 2023-01-01 → 2023-12-31 | ¥93m |
| Medical Technologiesreportable segment | revenue | 2023-01-01 → 2023-12-31 | ¥36.0bn |
| Medical Technologiesreportable segment | segment assets | at 2023-12-31 | ¥50.3bn |
| Medical Technologiesreportable segment | segment profit | 2023-01-01 → 2023-12-31 | ¥1.5bn |
| —segment total | revenue | 2023-01-01 → 2023-12-31 | ¥159.8bn |
| —segment total | segment assets | at 2023-12-31 | ¥139.4bn |
| —segment total | segment profit | 2023-01-01 → 2023-12-31 | ¥6m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-01-01 → 2023-12-31 | ¥168.9bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2023-12-31 | ¥150.1bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-01-01 → 2023-12-31 | −¥853m |
| Devicesreportable segment | employees | at 2024-12-31 | 185 pure |
| Industrial Materialsreportable segment | employees | at 2024-12-31 | 232 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 2,069
| Item | Context | Value | Unit |
|---|---|---|---|
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E00703-000IndustrialMaterialsReportableSegmentMember | 5441000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E00703-000DevicesReportableSegmentMember | 1485000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E00703-000MedicalTechnologiesReportableSegmentMember | 1824000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E00703-000OtherAndCorporateRAndDAdministrativeReportableSegmentMember | 859000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration | 9611000000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 50855638 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 50855638 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 50855638 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 50855638 | |
| Number of shares constituting one unit | CurrentYearInstant_OrdinaryShareMember | 100 | |
| Number of shareholders national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Number of shareholders financial institutions | CurrentYearInstant_OrdinaryShareMember | 31 | |
| Number of shareholders financial service providers | CurrentYearInstant_OrdinaryShareMember | 31 | |
| Number of shareholders other corporations | CurrentYearInstant_OrdinaryShareMember | 186 | |
| Number of shareholders foreign investors other than individuals | CurrentYearInstant_OrdinaryShareMember | 171 | |
| Number of shareholders foreign individual investors | CurrentYearInstant_OrdinaryShareMember | 15 | |
| Number of shareholders individuals and others | CurrentYearInstant_OrdinaryShareMember | 7816 | |
| Number of shareholders total | CurrentYearInstant_OrdinaryShareMember | 8250 | |
| Number of shares held number of units national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Number of shares held number of units financial institutions | CurrentYearInstant_OrdinaryShareMember | 165983 | |
| Number of shares held number of units financial service providers | CurrentYearInstant_OrdinaryShareMember | 14721 | |
| Number of shares held number of units other corporations | CurrentYearInstant_OrdinaryShareMember | 89433 | |
| Number of shares held number of units foreign investors other than individuals | CurrentYearInstant_OrdinaryShareMember | 132928 | |
| Number of shares held number of units foreign individual investors | CurrentYearInstant_OrdinaryShareMember | 47 | |
| Number of shares held number of units individuals and others | CurrentYearInstant_OrdinaryShareMember | 105010 | |
| Number of shares held number of units total | CurrentYearInstant_OrdinaryShareMember | 508122 | |
| Number of shares held shares less than one unit | CurrentYearInstant_OrdinaryShareMember | 43438 | |
| Percentage of shareholdings national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Percentage of shareholdings financial institutions | CurrentYearInstant_OrdinaryShareMember | 0.3266 | |
| Percentage of shareholdings financial service providers | CurrentYearInstant_OrdinaryShareMember | 0.0290 | |
| Percentage of shareholdings other corporations | CurrentYearInstant_OrdinaryShareMember | 0.1760 | |
| Percentage of shareholdings foreigners other than individuals | CurrentYearInstant_OrdinaryShareMember | 0.2616 | |
| Percentage of shareholdings foreign individuals | CurrentYearInstant_OrdinaryShareMember | 0.0001 | |
| Percentage of shareholdings individuals and others | CurrentYearInstant_OrdinaryShareMember | 0.2067 | |
| Number of shares held | CurrentYearInstant_No1MajorShareholdersMember | 4458000 | |
| Shareholding ratio | CurrentYearInstant_No1MajorShareholdersMember | 0.0925 | |
| Number of shares held | CurrentYearInstant_No2MajorShareholdersMember | 3203000 | |
| Shareholding ratio | CurrentYearInstant_No2MajorShareholdersMember | 0.0665 | |
| Number of shares held | CurrentYearInstant_No3MajorShareholdersMember | 2563000 | |
| Shareholding ratio | CurrentYearInstant_No3MajorShareholdersMember | 0.0532 | |
| Number of shares held | CurrentYearInstant_No4MajorShareholdersMember | 2107000 | |
| Shareholding ratio | CurrentYearInstant_No4MajorShareholdersMember | 0.0437 | |
| Number of shares held | CurrentYearInstant_No5MajorShareholdersMember | 2076000 | |
| Shareholding ratio | CurrentYearInstant_No5MajorShareholdersMember | 0.0431 | |
| Number of shares held | CurrentYearInstant_No6MajorShareholdersMember | 1442000 | |
| Shareholding ratio | CurrentYearInstant_No6MajorShareholdersMember | 0.0299 | |
| Number of shares held | CurrentYearInstant_No7MajorShareholdersMember | 1386000 | |
| Shareholding ratio | CurrentYearInstant_No7MajorShareholdersMember | 0.0287 | |
| Number of shares held | CurrentYearInstant_No8MajorShareholdersMember | 1352000 | |
| Shareholding ratio | CurrentYearInstant_No8MajorShareholdersMember | 0.0280 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 19 of 19 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |